BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33537239)

  • 1. 4-Hydroxyphenylpyruvate Dioxygenase-Like Protein Promotes Pancreatic Cancer Cell Progression and Is Associated With Glutamine-Mediated Redox Balance.
    Ye X; Wei X; Liao J; Chen P; Li X; Chen Y; Yang Y; Zhao Q; Sun H; Pan L; Chen G; He X; Lyu J; Fang H
    Front Oncol; 2020; 10():617190. PubMed ID: 33537239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 4-Hydroxyphenylpyruvate Dioxygenase-Like predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis.
    Li H; Liu J; Wang S; Xu Y; Tang Q; Ying G
    Aging (Albany NY); 2024 Mar; 16(5):4327-4347. PubMed ID: 38451188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biallelic variants in HPDL, encoding 4-hydroxyphenylpyruvate dioxygenase-like protein, lead to an infantile neurodegenerative condition.
    Ghosh SG; Lee S; Fabunan R; Chai G; Zaki MS; Abdel-Salam G; Sultan T; Ben-Omran T; Alvi JR; McEvoy-Venneri J; Stanley V; Patel A; Ross D; Ding J; Jain M; Pan D; Lübbert P; Kammerer B; Wiedemann N; Verhoeven-Duif NM; Jans JJ; Murphy D; Toosi MB; Ashrafzadeh F; Imannezhad S; Karimiani EG; Ibrahim K; Waters ER; Maroofian R; Gleeson JG
    Genet Med; 2021 Mar; 23(3):524-533. PubMed ID: 33188300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginine Methylation of MDH1 by CARM1 Inhibits Glutamine Metabolism and Suppresses Pancreatic Cancer.
    Wang YP; Zhou W; Wang J; Huang X; Zuo Y; Wang TS; Gao X; Xu YY; Zou SW; Liu YB; Cheng JK; Lei QY
    Mol Cell; 2016 Nov; 64(4):673-687. PubMed ID: 27840030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells.
    Srivastava S; Widmann S; Ho C; Nguyen D; Nguyen A; Premaratne A; Gustafsson JÅ; Lin CY
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial glutamine metabolism via GOT2 supports pancreatic cancer growth through senescence inhibition.
    Yang S; Hwang S; Kim M; Seo SB; Lee JH; Jeong SM
    Cell Death Dis; 2018 Jan; 9(2):55. PubMed ID: 29352139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspulvinone O, a natural inhibitor of GOT1 suppresses pancreatic ductal adenocarcinoma cells growth by interfering glutamine metabolism.
    Sun W; Luan S; Qi C; Tong Q; Yan S; Li H; Zhang Y
    Cell Commun Signal; 2019 Aug; 17(1):111. PubMed ID: 31470862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies.
    Xu R; Yang J; Ren B; Wang H; Yang G; Chen Y; You L; Zhao Y
    Front Oncol; 2020; 10():572722. PubMed ID: 33117704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity for Kras
    Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P
    Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
    Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
    Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic HSP60 regulates mitochondrial oxidative phosphorylation to support Erk1/2 activation during pancreatic cancer cell growth.
    Zhou C; Sun H; Zheng C; Gao J; Fu Q; Hu N; Shao X; Zhou Y; Xiong J; Nie K; Zhou H; Shen L; Fang H; Lyu J
    Cell Death Dis; 2018 Feb; 9(2):161. PubMed ID: 29415987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. KRAS-regulated glutamine metabolism requires UCP2-mediated aspartate transport to support pancreatic cancer growth.
    Raho S; Capobianco L; Malivindi R; Vozza A; Piazzolla C; De Leonardis F; Gorgoglione R; Scarcia P; Pezzuto F; Agrimi G; Barile SN; Pisano I; Reshkin SJ; Greco MR; Cardone RA; Rago V; Li Y; Marobbio CMT; Sommergruber W; Riley CL; Lasorsa FM; Mills E; Vegliante MC; De Benedetto GE; Fratantonio D; Palmieri L; Dolce V; Fiermonte G
    Nat Metab; 2020 Dec; 2(12):1373-1381. PubMed ID: 33230296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Mitochondrial Transporters on Metabolic Rewiring of Pancreatic Adenocarcinoma: A Comprehensive Review.
    Lauria G; Curcio R; Lunetti P; Tiziani S; Coppola V; Dolce V; Fiermonte G; Ahmed A
    Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness.
    Rademaker G; Hennequière V; Brohée L; Nokin MJ; Lovinfosse P; Durieux F; Gofflot S; Bellier J; Costanza B; Herfs M; Peiffer R; Bettendorff L; Deroanne C; Thiry M; Delvenne P; Hustinx R; Bellahcène A; Castronovo V; Peulen O
    Oncogene; 2018 Aug; 37(32):4398-4412. PubMed ID: 29720728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration.
    Sun Y; Wei X; Fang F; Shen Y; Wei H; Li J; Ye X; Zhan Y; Ye X; Liu X; Yang W; Li Y; Geng X; Huang X; Ruan Y; Qin Z; Yi S; Lyu J; Fang H; Yu Y
    J Genet Genomics; 2021 Aug; 48(8):727-736. PubMed ID: 34334354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monocarboxylate Transporter-1 (MCT1)-Mediated Lactate Uptake Protects Pancreatic Adenocarcinoma Cells from Oxidative Stress during Glutamine Scarcity Thereby Promoting Resistance against Inhibitors of Glutamine Metabolism.
    Ammar N; Hildebrandt M; Geismann C; Röder C; Gemoll T; Sebens S; Trauzold A; Schäfer H
    Antioxidants (Basel); 2023 Sep; 12(10):. PubMed ID: 37891897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
    Jeong SM; Hwang S; Park K; Yang S; Seong RH
    Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.